786 o line Search Results


786-o  (ATCC)
98
ATCC 786-o
786 O, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/786+o+line/custom%40crl-1932%4041220925?v=ATCC
Average 98 stars, based on 1 article reviews
786-o - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier
carcinoma 786 o cells  (Genecopoeia)
94
Genecopoeia carcinoma 786 o cells
Carcinoma 786 O Cells, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/786+o+line/pmc05727589-80-2-16?v=Genecopoeia
Average 94 stars, based on 1 article reviews
carcinoma 786 o cells - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
786o cancer cell line  (Cell Source Ltd)
90
Cell Source Ltd 786o cancer cell line
The role of SLC6A19 in ccRCC; (A) Univariate Cox regression for SLC6A19, SLC6A12 and SMIM24. (B) Differential expression of SLC6A19 between tumor and normal tissues in TCGA,GSE53757; (C) Differential expression of SLC6A19 in various clinical stages; (D) Immunohistochemical result from the HPA database showing SLC6A19 expression in normal tissue; (E) Immunohistochemical result from the HPA database showing SLC6A19 expression in ccRCC tissue; (F) Transwell assay showing the impact of SLC6A19 to invasive ability of 786O and <t>A498</t> cell lines; (G) CCK8 assay showing the impact of SLC6A19 to proliferation of 786O and A498 cell lines. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. ns, not significant.
786o Cancer Cell Line, supplied by Cell Source Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/786+o+line/pmc11911175-70-3-10?v=Cell+Source+Ltd
Average 90 stars, based on 1 article reviews
786o cancer cell line - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
786-o vhl −/− cell line  (Cayman Chemical)
90
Cayman Chemical 786-o vhl −/− cell line
The role of SLC6A19 in ccRCC; (A) Univariate Cox regression for SLC6A19, SLC6A12 and SMIM24. (B) Differential expression of SLC6A19 between tumor and normal tissues in TCGA,GSE53757; (C) Differential expression of SLC6A19 in various clinical stages; (D) Immunohistochemical result from the HPA database showing SLC6A19 expression in normal tissue; (E) Immunohistochemical result from the HPA database showing SLC6A19 expression in ccRCC tissue; (F) Transwell assay showing the impact of SLC6A19 to invasive ability of 786O and <t>A498</t> cell lines; (G) CCK8 assay showing the impact of SLC6A19 to proliferation of 786O and A498 cell lines. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. ns, not significant.
786 O Vhl −/− Cell Line, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/786+o+line/pmc03405842-204-3-13?v=Cayman+Chemical
Average 90 stars, based on 1 article reviews
786-o vhl −/− cell line - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
human renal cell carcinoma cell line 786-o  (European Collection of Authenticated Cell Cultures)
90
European Collection of Authenticated Cell Cultures human renal cell carcinoma cell line 786-o
The role of SLC6A19 in ccRCC; (A) Univariate Cox regression for SLC6A19, SLC6A12 and SMIM24. (B) Differential expression of SLC6A19 between tumor and normal tissues in TCGA,GSE53757; (C) Differential expression of SLC6A19 in various clinical stages; (D) Immunohistochemical result from the HPA database showing SLC6A19 expression in normal tissue; (E) Immunohistochemical result from the HPA database showing SLC6A19 expression in ccRCC tissue; (F) Transwell assay showing the impact of SLC6A19 to invasive ability of 786O and <t>A498</t> cell lines; (G) CCK8 assay showing the impact of SLC6A19 to proliferation of 786O and A498 cell lines. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. ns, not significant.
Human Renal Cell Carcinoma Cell Line 786 O, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/786+o+line/pmc11465592-81-1-12?v=European+Collection+of+Authenticated+Cell+Cultures
Average 90 stars, based on 1 article reviews
human renal cell carcinoma cell line 786-o - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
human renal cell carcinoma cell line 786-o  (iCell Bioscience Inc)
90
iCell Bioscience Inc human renal cell carcinoma cell line 786-o
The role of SLC6A19 in ccRCC; (A) Univariate Cox regression for SLC6A19, SLC6A12 and SMIM24. (B) Differential expression of SLC6A19 between tumor and normal tissues in TCGA,GSE53757; (C) Differential expression of SLC6A19 in various clinical stages; (D) Immunohistochemical result from the HPA database showing SLC6A19 expression in normal tissue; (E) Immunohistochemical result from the HPA database showing SLC6A19 expression in ccRCC tissue; (F) Transwell assay showing the impact of SLC6A19 to invasive ability of 786O and <t>A498</t> cell lines; (G) CCK8 assay showing the impact of SLC6A19 to proliferation of 786O and A498 cell lines. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. ns, not significant.
Human Renal Cell Carcinoma Cell Line 786 O, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/786+o+line/pm37527815-48-0-12?v=iCell+Bioscience+Inc
Average 90 stars, based on 1 article reviews
human renal cell carcinoma cell line 786-o - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
786-o cells  (CLS Cell Lines Service GmbH)
94
CLS Cell Lines Service GmbH 786-o cells
The role of SLC6A19 in ccRCC; (A) Univariate Cox regression for SLC6A19, SLC6A12 and SMIM24. (B) Differential expression of SLC6A19 between tumor and normal tissues in TCGA,GSE53757; (C) Differential expression of SLC6A19 in various clinical stages; (D) Immunohistochemical result from the HPA database showing SLC6A19 expression in normal tissue; (E) Immunohistochemical result from the HPA database showing SLC6A19 expression in ccRCC tissue; (F) Transwell assay showing the impact of SLC6A19 to invasive ability of 786O and <t>A498</t> cell lines; (G) CCK8 assay showing the impact of SLC6A19 to proliferation of 786O and A498 cell lines. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. ns, not significant.
786 O Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/786+o+line/custom%40300107%4029031061?v=CLS+Cell+Lines+Service+GmbH
Average 94 stars, based on 1 article reviews
786-o cells - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
786-o cell line  (National Centre for Cell Science)
90
National Centre for Cell Science 786-o cell line
The role of SLC6A19 in ccRCC; (A) Univariate Cox regression for SLC6A19, SLC6A12 and SMIM24. (B) Differential expression of SLC6A19 between tumor and normal tissues in TCGA,GSE53757; (C) Differential expression of SLC6A19 in various clinical stages; (D) Immunohistochemical result from the HPA database showing SLC6A19 expression in normal tissue; (E) Immunohistochemical result from the HPA database showing SLC6A19 expression in ccRCC tissue; (F) Transwell assay showing the impact of SLC6A19 to invasive ability of 786O and <t>A498</t> cell lines; (G) CCK8 assay showing the impact of SLC6A19 to proliferation of 786O and A498 cell lines. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. ns, not significant.
786 O Cell Line, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/786+o+line/10__1007_slash_s10600___022___03593___1-150-5-22?v=National+Centre+for+Cell+Science
Average 90 stars, based on 1 article reviews
786-o cell line - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
786-o gfp reporter cell line  (AcceGen Biotechnology)
N/A
The 786-O GFP cell line is transformed from 786-O cell, expressing the GFP gene. The cell constitutively express GFP.
   Buy from Supplier
786-o gfp and luciferase reporter cell line  (AcceGen Biotechnology)
N/A
The 786-O Luciferase GFP cell line is transformed from 786-O cell, expressing the GFP and luciferase gene. The cell constitutively express GFP and luciferase.
   Buy from Supplier
786-o [786-0] cell line  (Elabscience Biotechnology)
N/A
786-O [786-0] Cell Line
   Buy from Supplier
786-o human kidney adenocarcinoma cell line dual-labeled with luciferase and gfp  (Genecopoeia)
N/A
This product is a dual‐labeled stable pool in the designated cell type. This stable cell line expresses firefly luciferase and eGFP simultaneously. This cell line can be used in vitro for cancer cell line research
   Buy from Supplier

Image Search Results


The role of SLC6A19 in ccRCC; (A) Univariate Cox regression for SLC6A19, SLC6A12 and SMIM24. (B) Differential expression of SLC6A19 between tumor and normal tissues in TCGA,GSE53757; (C) Differential expression of SLC6A19 in various clinical stages; (D) Immunohistochemical result from the HPA database showing SLC6A19 expression in normal tissue; (E) Immunohistochemical result from the HPA database showing SLC6A19 expression in ccRCC tissue; (F) Transwell assay showing the impact of SLC6A19 to invasive ability of 786O and A498 cell lines; (G) CCK8 assay showing the impact of SLC6A19 to proliferation of 786O and A498 cell lines. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. ns, not significant.

Journal: Frontiers in Endocrinology

Article Title: Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes

doi: 10.3389/fendo.2025.1521940

Figure Lengend Snippet: The role of SLC6A19 in ccRCC; (A) Univariate Cox regression for SLC6A19, SLC6A12 and SMIM24. (B) Differential expression of SLC6A19 between tumor and normal tissues in TCGA,GSE53757; (C) Differential expression of SLC6A19 in various clinical stages; (D) Immunohistochemical result from the HPA database showing SLC6A19 expression in normal tissue; (E) Immunohistochemical result from the HPA database showing SLC6A19 expression in ccRCC tissue; (F) Transwell assay showing the impact of SLC6A19 to invasive ability of 786O and A498 cell lines; (G) CCK8 assay showing the impact of SLC6A19 to proliferation of 786O and A498 cell lines. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001. ns, not significant.

Article Snippet: The 786O and A498 cancer cell lines were purchased from CellSource China.

Techniques: Quantitative Proteomics, Immunohistochemical staining, Expressing, Transwell Assay, CCK-8 Assay